Epstein-Barr virus (EBV) is a human herpesvirus that causes widespread infection. It is found to be the causative agent of infectious mononucleosis and is closely associated with Burkitt's lymphoma (5), nasopharyngeal carcinoma (7), and EBV-induced disorders in immunodeficient patients (9) . However, only a handful of other epithelial-cell malignancies of the head and neck have been linked to EBV infection (2, 6, 14) .
Papillomaviruses, on the other hand, are members of the family Papovaviridae. To date, over 60 types of human papillomaviruses (HPV) have been identified. Like EBV, HPV infects squamous epithelia of the skin and mucosae. In addition to their involvement in benign neoplasms, HPV are implicated in several human cancers, particularly in tumors of the cervix, the anogenital region, the skin (18) , and the head and neck (1) . Recently, it was reported that both EBV and HPV were detected in oral epithelial tissues of AIDS patients (17) . Since both EBV and HPV can infect cells of epithelial origin and are closely associated with carcinomas, it was interesting to evaluate the infections caused by these two viruses in tumor cells.
In the present study, we describe our application of the polymerase chain reaction (PCR) method (15) and DNA sequencing analysis (16) (10) (11) (12) .
DNAs were obtained from the samples as described before (3) . Briefly, the homogenized tissues were treated with lysis buffer (0.5% sodium dodecyl sulfate, 10 mM Tris [pH 8.0], 10 mM EDTA) and 1 mg of proteinase K per ml, then purified with phenol-chloroform extraction, and finally precipitated with ethanol.
For PCR, primer set X (5'-AGAAACACGCGTTACTC TGA-3' and 5'-GGGTGTGGGGCAAAGGGTG-3'), corre- Because of the amplification power of the PCR procedures, special steps were taken to minimize the possibility of sample-to-sample contamination and PCR product carryover. These precautions included UV irradiation of the utensils before and after use and aliquoting of all reagents, including sample DNA.
RESULTS
Primer set X and PCR were used to examine the presence of EBV in tumor biopsy specimens and in normal tissues. A 497-bp band appeared after PCR, indicating the presence of EBV DNA in tumor tissues (Fig. 1A, lanes 2 to 6) . EBV DNA was found in all of the nasopharyngeal-carcinoma samples and in 30 of 44 various head and neck carcinoma biopsy samples. The latter 30 EBV-positive specimens included 8 of 12 hypopharyngeal-carcinoma samples, 6 of 10 laryngeal-carcinoma samples, 4 of 5 metastatic neck carcinoma samples, 4 of 9 oral-cavity carcinoma samples, and all of the samples collected from salivary-gland and paranasalsinus carcinoma tissues ( Table 1 ). The same result was obtained in all cases when the samples were reexamined a year later.
To evaluate the prevalence of HPV in this group of cancers, the PCR method and type-specific primers for HPV were used. For detection of HPV type 16 DNA in these samples with the first set (set 5R/5L) of the nested primers, the PCR products show a band of 445 bp on the 2% agarose gel after ethidium bromide staining. Subsequently, these first 1 2 3 4 (Fig. 2) . By using the methods described above, 14 of 30 nasopharyngeal-carcinoma samples were positive forHPV, and of the 44 other head and neck carcinoma biopsy specimens, 12 were found to be HPV DNA positive. Interestingly, laryngeal-carcinoma sample L-41 was found to contain bothHPV type 16 and HPV type 18. Among the 11 normal tissue samples, only 1 contained EBV and 1 contained HPV type 16 (Table 1) .
The PCR products were subcloned into pGEM3, and their sequences were determined to confirm EBV orHPV type 16 positivity in our samples. A total of 10 of the EBV-positive samples and 10 of the HPV type 16-positive samples were further confirmed by direct sequencing of the PCR products. The data indicated that all EBV-or HPV-positive samples contained the corresponding DNA sequences from the EBV and HPV type 16 viral genomes compared with the sequences obtained from the EMBL data base and from our positive controls. Figure 3A shows the sequence data of samples positive for EBV, and AGAAACACGC GTTACTC7GA CGTAGCCGCC CTACATAAGC CTCTCACACT GCTCTGCCCC   CTTCTTTCCT CAACTGCCTT GCTCCTGACA CACTGCCCTG AGGATGGAAC ACGACCTTGA  GAGGGGCCCA CCGGGCCCGC GACGGCCCCC TCGAGGACCC CCCCTCTCCT CTTCCCTAGG  CCTTGCTCTC CTTCTCCTCC TCTTGGCGCT ACTGTTTTGG CTGTACATCG TTATGAGTGA  CTGGACTGGA GGAGCCCTCC TTGTCCTCTA TTCCTTTGCT CTCATGCTTA TAATTATAAT  TTTGATCATC TTTATCTTCA GAAGAGACCT TCTCTGTCCA CTTGGAGCCC TTTGTATACT  CCTACTGATG AGTAAGTATT ACACCCTTTG CCCCACACCC CCTTTCCCTT ACTCTTCCTT  CTCTAACGCA CTTTCTCCTC TTTCCCCAGT CACCCTCCTG CTCATCGCTC TCTGGAATTT   GCACGGACAG GCATTGT   B HPV SE3UENE   CAATGTTTCA GGACCCACAG GAGCGACCCA GAAAGTTACC ACAGTTATG ACAGAGCTGC  AAACAACTAT ACATGATATA ATATTAGAAT GTGTGTACTG CAAGCAACAG TTACTGCGAC  GTGAGGTATA TGACTTTGCT TTTCGGGATT TATGCATAGT ATATAGAGAT GGGAATCCAT  ATGCTGTATG TGATAAATGT TTAAAGTTTT ATTCTAAAAT TAGTGAGTAT AGACATTATT  GTTATAGTTT GTATGGAACA ACATTAGAAC AGCAATACAA CAAACCGTTG TGTGATTTGT  TAATTAGGTG TATTAACTGT CAAAAGCCAC TGTGTCCTGA HPV type 16-corresponding sequences from these samples. Therefore, the PCR products indeed represent the presence of the virus sequences in the samples.
DISCUSSION
Nasopharyngeal carcinoma is a common cancer in Southeastern Asia and has been considered 1 of the top 10 malignant tumors in Taiwan. The data that we present indicate that EBV is closely associated with nasopharyngeal carcinoma as previously reported (3) . In addition, of the 30 nasopharyngeal-carcinoma samples studied, 14 were shown to contain HPV DNA sequence (Table 1 ; Fig. 1 ). Coinfection with EBV and HPV was detected in other head and neck carcinomas in addition to in nasopharyngeal carcinoma.
Three hypopharyngeal-carcinoma samples were positive for both EBV andHPV (Fig. 1A and B) . Although the correlation of the presence of EBV with hypopharyngeal carcinoma is not as strong as that with nasopharyngeal carcinoma, it suggests that the virus is possibly associated with this tumor.
Similarly, the correlation of HPV with either nasopharyngeal or hypopharyngeal carcinoma implies potential association of these tumors with HPV. EBV and HPV positivity in normal tissues from the oropharynx is low (<10% for EBV and HPV) compared with EBV and HPV positivity for nasopharyngeal carcinoma (100% for EBV and 47% for HPV) and hypopharyngeal carcinoma (67% for EBV and 58% forHPV) tissue samples. A total of 60% (6 of 10) of laryngeal-carcinoma samples contained EBV, but only 20% (2) In summary, by using sequence-specific primers and the sensitive PCR method (i.e., single copy) for detection of viral DNA in tissues (3, 11), we examined 30 nasopharyngealcarcinoma samples and 44 biopsy tissues of other head and neck tumors for the presence of EBV and HPV. Our data revealed that at least in some of the tumors, such as nasopharyngeal carcinoma and hypopharyngeal carcinoma, the viral infections are considered significantly frequent. Our data also indicated coinfection of EBV and HPV in samples of nasopharyngeal and hypopharyngeal carcinomas examined. This may suggest a possible role of synergistic effect or interaction of both viruses in the pathogenesis of such tumors. Further detailed studies at both molecular and cellular levels will be needed to confirm this relationship in oncogenesis.
